Hansa Biopharma to host conference call to provide half year results for January-June 2023 and a Business Update

/PRNewswire/ -- Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-June 2023 at 8:00 CET on July 20, 2023. All interested...

Related Keywords

Stockholm ,Sweden ,Tulstrup ,Hovedstaden ,Denmark ,Boston ,Massachusetts ,United States ,United Kingdom ,Copenhagen ,Køavn ,Prnewswire Hansa Biopharma ,Klaus Sindahl ,Hansa Biopharma ,Stephanie Kenney ,Donato Spota ,Matthew Shaulis ,Vp Global Corporate Affairs ,Erik Penser Company Day ,Nasdaq Stockholm ,Commercial Success ,Half Year Report ,Biopharma Conference ,Annual Global Investment Conference ,Morganstanley Global Healthcare Conference ,Pareto Annual Healthcare Conference ,Interim Report ,Ugebrev Life Science Event ,